nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—CYSLTR2—hematopoietic system—thymus cancer	0.0586	0.0979	CbGeAlD
Nedocromil—FPR1—hematopoietic system—thymus cancer	0.0527	0.0881	CbGeAlD
Nedocromil—PTGDR—hematopoietic system—thymus cancer	0.0498	0.0832	CbGeAlD
Nedocromil—FPR1—lymphoid tissue—thymus cancer	0.0371	0.0621	CbGeAlD
Nedocromil—CYSLTR2—lung—thymus cancer	0.034	0.0569	CbGeAlD
Nedocromil—FPR1—bone marrow—thymus cancer	0.0338	0.0565	CbGeAlD
Nedocromil—PTGDR—bone marrow—thymus cancer	0.0319	0.0534	CbGeAlD
Nedocromil—FPR1—lung—thymus cancer	0.0306	0.0512	CbGeAlD
Nedocromil—PTGDR—lung—thymus cancer	0.0289	0.0483	CbGeAlD
Nedocromil—HSP90AA1—neck—thymus cancer	0.0257	0.043	CbGeAlD
Nedocromil—Otitis media—Octreotide—thymus cancer	0.0236	0.073	CcSEcCtD
Nedocromil—Stinging—Octreotide—thymus cancer	0.0227	0.0701	CcSEcCtD
Nedocromil—CYSLTR1—hematopoietic system—thymus cancer	0.022	0.0369	CbGeAlD
Nedocromil—Viral infection—Octreotide—thymus cancer	0.0204	0.0629	CcSEcCtD
Nedocromil—PTGDR—lymph node—thymus cancer	0.0198	0.0331	CbGeAlD
Nedocromil—HSP90AA1—hematopoietic system—thymus cancer	0.0191	0.032	CbGeAlD
Nedocromil—HSP90AA1—epithelium—thymus cancer	0.0175	0.0292	CbGeAlD
Nedocromil—CYSLTR1—lymphoid tissue—thymus cancer	0.0155	0.0259	CbGeAlD
Nedocromil—Gastroenteritis—Octreotide—thymus cancer	0.0151	0.0465	CcSEcCtD
Nedocromil—Nasal congestion—Octreotide—thymus cancer	0.0146	0.0453	CcSEcCtD
Nedocromil—HSP90AA1—cardiac atrium—thymus cancer	0.0145	0.0243	CbGeAlD
Nedocromil—HSP90AA1—pituitary gland—thymus cancer	0.0142	0.0237	CbGeAlD
Nedocromil—CYSLTR1—bone marrow—thymus cancer	0.0141	0.0236	CbGeAlD
Nedocromil—Arthritis—Octreotide—thymus cancer	0.0137	0.0424	CcSEcCtD
Nedocromil—HSP90AA1—lymphoid tissue—thymus cancer	0.0135	0.0225	CbGeAlD
Nedocromil—CYSLTR1—lung—thymus cancer	0.0128	0.0214	CbGeAlD
Nedocromil—HSP90AA1—Semaphorin interactions—DPYSL5—thymus cancer	0.0125	0.16	CbGpPWpGaD
Nedocromil—HSP90AA1—bone marrow—thymus cancer	0.0123	0.0205	CbGeAlD
Nedocromil—HSP90AA1—thyroid gland—thymus cancer	0.0122	0.0204	CbGeAlD
Nedocromil—Influenza—Octreotide—thymus cancer	0.0115	0.0356	CcSEcCtD
Nedocromil—HSP90AA1—lung—thymus cancer	0.0111	0.0186	CbGeAlD
Nedocromil—Bronchitis—Octreotide—thymus cancer	0.0111	0.0343	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Octreotide—thymus cancer	0.0107	0.0331	CcSEcCtD
Nedocromil—Pneumonia—Octreotide—thymus cancer	0.0103	0.032	CcSEcCtD
Nedocromil—Conjunctivitis—Octreotide—thymus cancer	0.01	0.0309	CcSEcCtD
Nedocromil—Sinusitis—Octreotide—thymus cancer	0.00965	0.0298	CcSEcCtD
Nedocromil—Rhinitis—Octreotide—thymus cancer	0.00925	0.0286	CcSEcCtD
Nedocromil—Pharyngitis—Octreotide—thymus cancer	0.00916	0.0283	CcSEcCtD
Nedocromil—Visual impairment—Octreotide—thymus cancer	0.0089	0.0275	CcSEcCtD
Nedocromil—CYSLTR1—lymph node—thymus cancer	0.00876	0.0146	CbGeAlD
Nedocromil—HSP90AA1—lymph node—thymus cancer	0.0076	0.0127	CbGeAlD
Nedocromil—Tremor—Octreotide—thymus cancer	0.00753	0.0233	CcSEcCtD
Nedocromil—Cough—Octreotide—thymus cancer	0.00701	0.0217	CcSEcCtD
Nedocromil—Chest pain—Octreotide—thymus cancer	0.00684	0.0211	CcSEcCtD
Nedocromil—Dry mouth—Octreotide—thymus cancer	0.00669	0.0207	CcSEcCtD
Nedocromil—Anaphylactic shock—Octreotide—thymus cancer	0.00656	0.0203	CcSEcCtD
Nedocromil—Dyspnoea—Octreotide—thymus cancer	0.00585	0.0181	CcSEcCtD
Nedocromil—Dyspepsia—Octreotide—thymus cancer	0.00577	0.0178	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Octreotide—thymus cancer	0.00566	0.0175	CcSEcCtD
Nedocromil—Fatigue—Octreotide—thymus cancer	0.00565	0.0175	CcSEcCtD
Nedocromil—Pain—Octreotide—thymus cancer	0.00561	0.0173	CcSEcCtD
Nedocromil—Gastrointestinal pain—Octreotide—thymus cancer	0.00536	0.0166	CcSEcCtD
Nedocromil—Urticaria—Octreotide—thymus cancer	0.00521	0.0161	CcSEcCtD
Nedocromil—Abdominal pain—Octreotide—thymus cancer	0.00518	0.016	CcSEcCtD
Nedocromil—Body temperature increased—Octreotide—thymus cancer	0.00518	0.016	CcSEcCtD
Nedocromil—Hypersensitivity—Octreotide—thymus cancer	0.00483	0.0149	CcSEcCtD
Nedocromil—Asthenia—Octreotide—thymus cancer	0.00471	0.0145	CcSEcCtD
Nedocromil—Diarrhoea—Octreotide—thymus cancer	0.00449	0.0139	CcSEcCtD
Nedocromil—Dizziness—Octreotide—thymus cancer	0.00434	0.0134	CcSEcCtD
Nedocromil—HSP90AA1—Hypoxic and oxygen homeostasis regulation of HIF-1-alpha—CDKN2A—thymus cancer	0.00425	0.0544	CbGpPWpGaD
Nedocromil—Vomiting—Octreotide—thymus cancer	0.00417	0.0129	CcSEcCtD
Nedocromil—Rash—Octreotide—thymus cancer	0.00414	0.0128	CcSEcCtD
Nedocromil—Dermatitis—Octreotide—thymus cancer	0.00413	0.0128	CcSEcCtD
Nedocromil—Headache—Octreotide—thymus cancer	0.00411	0.0127	CcSEcCtD
Nedocromil—Nausea—Octreotide—thymus cancer	0.0039	0.012	CcSEcCtD
Nedocromil—HSP90AA1—eNOS activation—AKT1—thymus cancer	0.00363	0.0465	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—DPYSL5—thymus cancer	0.00356	0.0455	CbGpPWpGaD
Nedocromil—HSP90AA1—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—thymus cancer	0.00289	0.0369	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—DPYSL5—thymus cancer	0.00254	0.0325	CbGpPWpGaD
Nedocromil—HSP90AA1—Hypoxic and oxygen homeostasis regulation of HIF-1-alpha—TP53—thymus cancer	0.00237	0.0303	CbGpPWpGaD
Nedocromil—HSP90AA1—IL2 signaling events mediated by PI3K—IL2—thymus cancer	0.00216	0.0277	CbGpPWpGaD
Nedocromil—PTGDR—Thromboxane A2 receptor signaling—AKT1—thymus cancer	0.00216	0.0276	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism of nitric oxide—AKT1—thymus cancer	0.002	0.0256	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—IL2—thymus cancer	0.00182	0.0232	CbGpPWpGaD
Nedocromil—CYSLTR2—Endothelins—AKT1—thymus cancer	0.00154	0.0197	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFR2 mediated vascular permeability—AKT1—thymus cancer	0.00147	0.0187	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFR1 specific signals—AKT1—thymus cancer	0.00142	0.0182	CbGpPWpGaD
Nedocromil—HSP90AA1—Regulation of Telomerase—IL2—thymus cancer	0.00133	0.017	CbGpPWpGaD
Nedocromil—HSP90AA1—LKB1 signaling events—TP53—thymus cancer	0.00123	0.0157	CbGpPWpGaD
Nedocromil—HSP90AA1—Class I PI3K signaling events mediated by Akt—AKT1—thymus cancer	0.00123	0.0157	CbGpPWpGaD
Nedocromil—HSP90AA1—IL2 signaling events mediated by PI3K—AKT1—thymus cancer	0.00117	0.015	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—IL2—thymus cancer	0.00114	0.0146	CbGpPWpGaD
Nedocromil—CYSLTR1—Endothelins—AKT1—thymus cancer	0.00107	0.0136	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—IL2—thymus cancer	0.00104	0.0133	CbGpPWpGaD
Nedocromil—HSP90AA1—Integrin-linked kinase signaling—AKT1—thymus cancer	0.001	0.0128	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—KIT—thymus cancer	0.000938	0.012	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CYLD—thymus cancer	0.000931	0.0119	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—KIT—thymus cancer	0.000863	0.011	CbGpPWpGaD
Nedocromil—HSP90AA1—Integrins in angiogenesis—AKT1—thymus cancer	0.000766	0.0098	CbGpPWpGaD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—thymus cancer	0.000757	0.00968	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MAML2—thymus cancer	0.000738	0.00944	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—thymus cancer	0.000735	0.0094	CbGpPWpGaD
Nedocromil—HSP90AA1—Regulation of Telomerase—AKT1—thymus cancer	0.000721	0.00922	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—thymus cancer	0.000721	0.00922	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MAML2—thymus cancer	0.000713	0.00912	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—AKT1—thymus cancer	0.00062	0.00793	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—AKT1—thymus cancer	0.000566	0.00724	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—AKT1—thymus cancer	0.000566	0.00724	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MAML2—thymus cancer	0.00056	0.00716	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CYLD—thymus cancer	0.000542	0.00693	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—CDKN2A—thymus cancer	0.000518	0.00663	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—AKT1—thymus cancer	0.000501	0.00641	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—AKT1—thymus cancer	0.000473	0.00605	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—IL2—thymus cancer	0.000447	0.00572	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—IL2—thymus cancer	0.000432	0.00552	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL2—thymus cancer	0.000406	0.00519	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MAML2—thymus cancer	0.000398	0.00508	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL2—thymus cancer	0.000392	0.00502	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAML2—thymus cancer	0.000388	0.00496	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—AKT1—thymus cancer	0.000358	0.00458	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—KIT—thymus cancer	0.000341	0.00437	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—KIT—thymus cancer	0.000341	0.00436	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—IL2—thymus cancer	0.000339	0.00433	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—AKT1—thymus cancer	0.000329	0.00421	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—KIT—thymus cancer	0.000329	0.00421	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDKN2A—thymus cancer	0.000325	0.00416	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL2—thymus cancer	0.000308	0.00394	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDKN2A—thymus cancer	0.000291	0.00372	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—TP53—thymus cancer	0.000288	0.00369	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAML2—thymus cancer	0.000278	0.00356	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD8A—thymus cancer	0.000265	0.00339	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CD4—thymus cancer	0.000261	0.00334	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KIT—thymus cancer	0.000258	0.0033	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AKT1—thymus cancer	0.000242	0.0031	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL2—thymus cancer	0.00024	0.00307	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—IL2—thymus cancer	0.000235	0.003	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AKT1—thymus cancer	0.000234	0.00299	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL2—thymus cancer	0.000232	0.00296	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AKT1—thymus cancer	0.00022	0.00282	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL2—thymus cancer	0.000213	0.00273	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AKT1—thymus cancer	0.000213	0.00272	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—KIT—thymus cancer	0.000199	0.00254	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AKT1—thymus cancer	0.000184	0.00235	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—KIT—thymus cancer	0.000184	0.00235	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL2—thymus cancer	0.000182	0.00232	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KIT—thymus cancer	0.000179	0.00229	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AKT1—thymus cancer	0.000167	0.00213	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—thymus cancer	0.000162	0.00207	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—thymus cancer	0.000154	0.00197	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD4—thymus cancer	0.000152	0.00194	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—thymus cancer	0.000149	0.0019	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—AKT1—thymus cancer	0.000147	0.00189	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CD4—thymus cancer	0.00014	0.0018	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL2—thymus cancer	0.00014	0.00179	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—AKT1—thymus cancer	0.00013	0.00167	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AKT1—thymus cancer	0.00013	0.00166	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KIT—thymus cancer	0.000129	0.00164	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AKT1—thymus cancer	0.000127	0.00163	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL2—thymus cancer	0.000126	0.00161	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AKT1—thymus cancer	0.000126	0.00161	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—thymus cancer	0.000117	0.00149	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AKT1—thymus cancer	0.000116	0.00148	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AKT1—thymus cancer	9.86e-05	0.00126	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL2—thymus cancer	9.05e-05	0.00116	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—thymus cancer	8.09e-05	0.00103	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AKT1—thymus cancer	7.59e-05	0.00097	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—AKT1—thymus cancer	7e-05	0.000896	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKT1—thymus cancer	6.83e-05	0.000874	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AKT1—thymus cancer	5.87e-05	0.00075	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—thymus cancer	5.81e-05	0.000743	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKT1—thymus cancer	4.9e-05	0.000627	CbGpPWpGaD
